BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mak LY, To WP, Wong DKH, Fung J, Liu F, Seto WK, Lai CL, Yuen MF. Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients. World J Gastroenterol 2019; 25(11): 1398-1408 [PMID: 30918432 DOI: 10.3748/wjg.v25.i11.1398]
URL: https://www.wjgnet.com/1007-9327/full/v25/i11/1398.htm
Number Citing Articles
1
Alessia Virzì, Victor Gonzalez-Motos, Simona Tripon, Thomas F. Baumert, Joachim Lupberger. Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker DevelopmentJournal of Clinical Medicine 2021; 10(5): 977 doi: 10.3390/jcm10050977
2
James Lok, Kosh Agarwal. Screening for Hepatocellular Carcinoma in Chronic Hepatitis B: An UpdateViruses 2021; 13(7): 1333 doi: 10.3390/v13071333
3
Ian Baudi, Takako Inoue, Yasuhito Tanaka. Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGiInternational Journal of Molecular Sciences 2020; 21(3): 949 doi: 10.3390/ijms21030949
4
Shu Feng, Zhonghao Wang, Yanhua Zhao, Chuanmin Tao. Wisteria floribunda agglutinin-positive Mac-2-binding protein as a diagnostic biomarker in liver cirrhosis: an updated meta-analysisScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-67471-y
5
Takako Inoue, Yasuhito Tanaka. Novel biomarkers for the management of chronic hepatitis BClinical and Molecular Hepatology 2020; 26(3): 261 doi: 10.3350/cmh.2020.0032